Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Gut Immune System Discovery Opens Door to More Targeted Food Allergy Therapies

Researchers Test a Probiotic as a Potential Treatment for Food Allergy

Food Allergy Treatment Market Is Set to Triple — What it Means for Patients

Microbiome Therapies Show Potential in Food Allergy Research

Sublingual Epinephrine Advances as FDA Clarifies Requirements for Approval

Gene Therapy Successfully Treats Mice with Food Allergies

Aquestive’s Sublingual Emergency Epinephrine Compares Favorably to EpiPen® in EPIPHAST II...

Private Law Firm to Investigate Claims on Behalf of Investors in...

FDA Issues Partial Hold on DBV Viaskin Peanut Patch Trial

Study Finds Biologic Drug Highly Effective in Reducing Pediatric Eczema Symptoms

DBV Begins Phase 3 Study of Redesigned Viaskin Peanut Patch in...

Bryn Pharma Completes Study of Nasal Epinephrine vs Auto-Injector for Anaphylaxis

Food Allergies Reversed in Mice by Targeting the Microbiome

ALK Starts Clinical Trial of SLIT Tablet to Treat Peanut Allergy

United Biopharma’s Monoclonal Antibody Shows Promise in Neutralizing IgE

Follow Us

Your School On Our Map

Put Your School on the Map